Capital increase with board delegation: the registrar cannot block it due to the meeting notice

Key data

A capital increase of €2,670,000 was blocked at the Madrid Commercial Register due to a formal defect in the shareholders' meeting notice. The registrar understood that the shareholder's right to information regulated in art. 287 of the Capital Companies Law (LSC) had not been complied with. The company appealed and the DGSJFP ruled in its favor: when the shareholders' meeting has delegated to the board the power to increase capital—the so-called "authorized capital" of art. 297 LSC—the information requirements of the notice are different and express mention of that article in the agenda is sufficient.

The resolution, published on June 17, 2026, has direct implications for any joint-stock company that has activated or wants to activate the authorized capital mechanism.

What does this regulation establish?

The resolution addresses a technical debate with very practical consequences: what information must the shareholders' meeting notice contain when the agenda includes delegation to the board to increase capital?

Art. 287 LSC requires that when a shareholders' meeting is called to amend bylaws, shareholders have prior access to the information necessary to vote with knowledge of the facts. The registrar applied this provision strictly and denied the registration of the subsequent capital increase executed by the board, understanding that the original notice did not sufficiently detail the terms of the statutory amendment.

The DGSJFP establishes a key distinction:

• When the shareholders' meeting directly approves a closed statutory amendment (amount, issue price, conditions), art. 287 LSC requires complete and prior information.
• When the shareholders' meeting delegates to the board the power to increase capital under art. 297 LSC, there is no closed statutory amendment at that time. The adaptation is subsequent, quantitative and executed by the board within the authorized margin.
• In this second case, express mention of art. 297 LSC in the agenda is sufficient to satisfy shareholders' right to information.

Consequently, the registrar exceeded the limits of its registration control by applying to authorized capital the same formal requirements as to an ordinary statutory amendment.

Economic and operational impact

The immediate impact is the unblocking of the registration of the €2,670,000 capital increase. But the structural impact is greater: this resolution reduces legal uncertainty for all joint-stock companies that use or plan to use authorized capital as an agile financing tool.

Before this resolution, there was a risk that the registrar would require, in order to register the execution of authorized capital, that the original shareholders' meeting notice had detailed all the terms of the future capital increase—something that by definition is not possible at the time of delegation. That criterion generated uncertainty and could paralyze financing operations at critical moments.

The specific operational effects are:

• Reduction of the risk of registration blockage in capital increases executed by the board under authorized capital.
• Greater agility in capital raising: the board can execute the capital increase without the need to reconvene the shareholders' meeting or expand the informational content of the original notice.
• Clarification of the limits of registration control: the registrar cannot require information requirements specific to art. 287 LSC when the operation is covered by art. 297 LSC.

Who does it affect?

• Joint-stock companies that have approved or want to approve a delegation of authorized capital to the board of directors (art. 297 LSC).
• Boards of directors that execute or will execute capital increases within the margin authorized by the shareholders' meeting.
• Commercial registrars, whose margin of control is limited in these cases.
• Legal advisors and notaries who draft shareholders' meeting notices or capital increase deeds in joint-stock companies.
• CFOs and financial directors of joint-stock companies that use authorized capital as a recurring financing instrument.

Practical example

A joint-stock company approves at a shareholders' meeting a delegation to the board of directors to increase capital by up to €3,000,000 over the next five years, with express mention of art. 297 LSC in the agenda of the notice. Two years later, the board decides to execute a capital increase of €2,670,000—exactly the amount of the resolved case—to finance a strategic acquisition.

The commercial registrar denies the registration of the capital increase deed alleging that the original shareholders' meeting notice did not detail the issue price or the specific conditions of the capital increase, violating art. 287 LSC.

According to the DGSJFP resolution, that rejection is improper: the mention of art. 297 LSC in the agenda is sufficient, because at the time of the shareholders' meeting there was no closed statutory amendment to report. The board can execute the capital increase within the authorized margin without the need to reconvene the shareholders' meeting or remedy the original notice. Registration must be admitted.

What should companies do now?

1. Review the bylaws: check if your joint-stock company has an active delegation of authorized capital under art. 297 LSC and what is the available margin (amount and term).
2. Verify future notices: when the approval or renewal of a delegation of authorized capital is included in the agenda, ensure that express mention of art. 297 LSC appears. That is sufficient for the purpose of the right to information.
3. Do not over-dimension the informational content of the notice: it is not necessary—nor possible—to detail in the notice the specific terms of a future capital increase that the board will execute. Doing so can create confusion about the type of operation.
4. In case of registration rejection in this case, appeal: if the registrar denies the registration of a capital increase executed under authorized capital alleging information defects in the notice, this DGSJFP resolution supports the appeal.
5. Consult with a legal advisor before executing relevant capital increases to ensure that the deed complies with formal requirements beyond the right to information in the notice.

Official source

Consult complete regulation at official source

Notice: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-13174